Difference between revisions of "The Future of Biotechnology for Medical Applications in 2005, Biotech Financial"

From ScenarioThinking
Jump to navigation Jump to search
Line 1: Line 1:
1. What is the market cap of Biotechnology in the healthcare sector
''1. What is the market cap of Biotechnology in the healthcare sector''


[[Image:market cap healthcare sector.JPG]]
[[Image:market cap healthcare sector.JPG]]




11.What percentage of the turnover of the pharmaceutical industry is generated by
''2.What percentage of the turnover of the pharmaceutical industry is generated by
biotech drugs, what percentage is generated by classical drugs?
biotech drugs, what percentage is generated by classical drugs?''


[[Image:turnover of biotech drugs.JPG]]
[[turnover of biotech drugs.JPG]]


P/E of biotech sector based on the average of all applicable price earnings reports of biotech companies. Many companies report a N/A price earnings ratio since they have a negative net income.
P/E of biotech sector based on the average of all applicable price earnings reports of biotech companies. Many companies report a N/A price earnings ratio since they have a negative net income.




29. Is/Can the cost structure of bio-pharmaceuticals be structurally lower than that of ordinary pharmaceuticals?
''3. Is/Can the cost structure of bio-pharmaceuticals be structurally lower than that of ordinary pharmaceuticals?''


The gross margin for biotech companies  (ranked by market cap) is shown below
The gross margin for biotech companies  (ranked by market cap) is shown below


The gross margin for biotech companies (ranked by market cap) is shown below
[[cost structure biotech.JPG]]


The gross margin for pharma companies (ranked by market cap) is shown below
[[cost structure pharma.JPG]]


Conclusion: No visible difference between cost structure of biotech companies as compared to pharma companies
Conclusion: No visible difference between cost structure of biotech companies as compared to pharma companies




?. How do investments in the biotechnology sector compare to that in the pharma industry?
''4. How does the financing structure of biotech companies look like and compare with pharma?''
 
No data found
 
 
?. How does the financing structure of biotech companies look like and compare with pharma?


Most pharma and bio tech companies are fully equity financed. Have very little debt
Most pharma and bio tech companies are fully equity financed. Have very little debt


 
''5. What is the expected 5 year growth rate of the biotech industry as compared to the pharma industry?''
 
 
 
 
?. What is the expected 5 year growth rate of the biotech industry as compared to the pharma industry


Expected 5 year growth rate of major biotech companies (ranked by market cap) is below
Expected 5 year growth rate of major biotech companies (ranked by market cap) is below


[[growth biotech.JPG]]


Expected 5 year growth rate of major pharma companies (ranked by market cap) is below
Expected 5 year growth rate of major pharma companies (ranked by market cap) is below


 
[[growth pharma.JPG]]


Conclusion: Biotech companies are averaging a growth rate of 20%, while pharma about 8%
Conclusion: Biotech companies are averaging a growth rate of 20%, while pharma about 8%

Revision as of 09:34, 23 November 2005

1. What is the market cap of Biotechnology in the healthcare sector

Market cap healthcare sector.JPG


2.What percentage of the turnover of the pharmaceutical industry is generated by biotech drugs, what percentage is generated by classical drugs?

turnover of biotech drugs.JPG

P/E of biotech sector based on the average of all applicable price earnings reports of biotech companies. Many companies report a N/A price earnings ratio since they have a negative net income.


3. Is/Can the cost structure of bio-pharmaceuticals be structurally lower than that of ordinary pharmaceuticals?

The gross margin for biotech companies (ranked by market cap) is shown below

cost structure biotech.JPG

The gross margin for pharma companies (ranked by market cap) is shown below

cost structure pharma.JPG

Conclusion: No visible difference between cost structure of biotech companies as compared to pharma companies


4. How does the financing structure of biotech companies look like and compare with pharma?

Most pharma and bio tech companies are fully equity financed. Have very little debt

5. What is the expected 5 year growth rate of the biotech industry as compared to the pharma industry?

Expected 5 year growth rate of major biotech companies (ranked by market cap) is below

growth biotech.JPG

Expected 5 year growth rate of major pharma companies (ranked by market cap) is below

growth pharma.JPG

Conclusion: Biotech companies are averaging a growth rate of 20%, while pharma about 8%

Most important financial drivers

1. Expected growth rates (determines investments) 2. Net profit margins 3. Return on equity